Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Settlement, a potential problem.

With equal due respect, the stipulated judgment on the '584 was without prejudice, that means the '584 can be litigated again, with the J3/ARM as defendants.

The stipulated judgment only removed the '584 from the current litigation, not forever. Also, TPL are appealing the '584 claim construction, as you have posted.

 

 

Be well

Share
New Message
Please login to post a reply